| Host defenses against zygomycetes. | |
| | |
MedLine Citation:
|
PMID: 22247447 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Mucormycosis is a devastating disease and can occur in patients with a variety of risk factors, the most important of which are immunosuppression, anatomic barrier breakdown, iron overload, and hyperglycemia/acidosis. Similarly to what occurs with Aspergillus, the host stimulates an innate immune response against the challenging sporangiospores and invading hyphae of Zygomycetes. This article discusses the host defense to different Zygomycetes, its augmentation, and its subsequent impact on the outcome of mucormycosis. |
| | |
Authors:
|
Emmanuel Roilides; Dimitrios P Kontoyiannis; Thomas J Walsh |
Related Documents
:
|
21576947 - The antimicrobial skin barrier in patients with atopic dermatitis. 9596657 - Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo e... 22194707 - Antimicrobial peptides in innate immunity against mycobacteria. 2515087 - Toxicology studies of a chemical mixture of 25 groundwater contaminants. ii. immunosupp... 16006537 - Cytokines and cardiovascular disease. 20392497 - Antimicrobial peptide rcramp induced glial cell activation through p2y receptor signall... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Volume: 54 Suppl 1 ISSN: 1537-6591 ISO Abbreviation: Clin. Infect. Dis. Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9203213 Medline TA: Clin Infect Dis Country: United States |
Other Details:
|
Languages: eng Pagination: S61-6 Citation Subset: IM |
Affiliation:
|
Third Department of Pediatrics, Aristotle University, Hippokration Hospital, Thessaloniki, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated muco...
Next Document: How does antifungal pharmacology differ for mucormycosis versus aspergillosis?